Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept

British Journal of Dermatology

Volumn 160, Issue 1, 2009, Pages 186-189

  Wolf, P ^a   Hofer, A ^a   Legat, F J ^a   Bretterklieber, A ^a   Weger, W ^a   Salmhofer, W ^a   Kerl, H ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

311 nm; Combination therapy; Etanercept; Psoriasis; Ultraviolet

Indexed keywords

ETANERCEPT;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DRUG SAFETY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS; RADIATION DOSE; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 57649174137     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08926.x     Document Type: Article

References (11)

1. Leonardi CL, Powers JL, Matheson RT et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003 349 : 2014 22.
2. Paller AS, Siegfried EC, Langley RG et al. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med 2008 358 : 241 51.
3. Legat FJ, Hofer A, Wackernagel A et al. Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis. Arch Dermatol 2007 143 : 1016 22.
4. Legat FJ, Quehenberger F, Wolf P. The role of narrowband UV-B plus alefacept combination therapy in the treatment of psoriasis (reply to Jacobe et al.). Arch Dermatol 2008 144 : 1068 9.
5. Kircik L, Bagel J, Korman N et al. Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes. J Drugs Dermatol 2008 7 : 245 53.
6. Driessen RJ, van de Kerkhof PC, de Jong EM. Etanercept combined with methotrexate for high-need psoriasis. Br J Dermatol 2008 159 : 460 3.
7. Gisondi P, Del Giglio M, Cotena C et al. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial. Br J Dermatol 2008 158 : 1345 9.
8. Hofer A, Fink-Puches R, Kerl H et al. Comparison of phototherapy with near vs. far erythemogenic doses of narrow-band ultraviolet B in patients with psoriasis. Br J Dermatol 1998 138 : 96 100.
9. Legat FJ, Hofer A, Quehenberger F et al. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA. J Am Acad Dermatol 2004 51 : 746 54.
10. Stern RS. Psoralen and ultraviolet A light therapy for psoriasis. N Engl J Med 2007 357 : 682 90.
11. Krueger GG, Langley RG, Leonardi C et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 2007 356 : 580 92.